BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
BioPharm Executive - Money Talk
Redwood City Biopharma, Versartis, Inc. (VSAR), Hits High End With $126 Million IPO 3/21/2014  More...
Cambridge's Akebia Therapeutics, Inc. (AKBA) Hauls In $100 Million In Upsized IPO Debut 3/20/2014  More...
Circassia Limited (CIR.L) Raises $332 Million In IPO Debut, Largest Biotech IPO Since 1995 3/14/2014  More...
San Diego Biopharma Lumena Pharmaceuticals Secures $45 Million In Series B Financing Round 3/11/2014  More...
Billionaire-Backed San Diego Startup, Human Longevity Inc., Gets $70 Million To Take On Aging 3/7/2014  More...
NovImmune SA Finishes $66 Million Series B Financing Round 2/18/2014  More...
Flexion Therapeutics (FLXN) Pulls Off $60 Million In IPO Debut 2/12/2014  More...
NephroGenex (NRX) Prices IPO At Low End Of Range, Will Reap About $37.2 Million 2/11/2014  More...
Argos Therapeutics, Inc. (ARGS) Prices Lower Than Expected IPO, Raises $45 Million 2/7/2014  More...
Eleven Biotherapeutics (EBIO) Prices Downsized IPO, Grabs $50 Million 2/6/2014  More...
Already-Rich Startup, Juno Therapeutics, Expands Series A Funding Round To $145 Million 1/15/2014  More...
Sanofi (France) (SAN.PA) Pays $700 Million For 12 Percent Of Alnylam Pharmaceuticals (ALNY) 1/13/2014  More...
Alkermes plc (ALKS) Hauls In $250 Million It Doesn't Need, But It May Prevent It From Being Swallowed Up 1/13/2014  More...
Amgen (AMGN)'s Bay Area Spinoff, Atara Biotherapeutics, Hauls In $52 Million Series B Financing 1/10/2014  More...
GlycoMimetics, Inc. (GLYC) Finally Prices Upraised IPO At $8 Per Share 1/10/2014  More...
Early Stage Biotech VC, 5AM Ventures, Grabs $250 Million 12/5/2013  More...
Biotech Startup, Juno Therapeutics, Grabs $120 Million To Coax Immune System To Fight Cancer 12/5/2013  More...
NYCEDC's $100 Million Biotech Fund Aims To Form 15 To 20 New Startups By 2020 12/4/2013  More...
Zafgen Racks Up $45 Million Series E Round 12/4/2013  More...
Orexigen Therapeutics, Inc. (OREX) Offers $100 Million Of Convertible Senior Notes 12/3/2013  More...
San Diego’s Vital Therapies, Inc. (VTI) Postpones IPO As Biotech Sector Cools Off 11/22/2013  More...
Evogene Ltd. (EVGN) Hauls In $74 Million In IPO 11/21/2013  More...
Flagship VentureLabs Takes A Stab At Microbiome Therapy By Launching New Biotech Seres Health 11/21/2013  More...
Pfizer Inc. (PFE) Sees Something Special In MissionTherapeutics Ltd, Backs Co With $32 Million Series B 11/18/2013  More...
Karyopharm Therapeutics (KPTI) Raises $109 Million in Upsized IPO, Begins Trading Today 11/6/2013  More...
Pronutria Emerges From Stealth With $10.8 Million, Nutrients to Treat Disease 10/22/2013  More...
Cancer Biotech TetraLogic Pharmaceuticals Files for a $104 Million IPO 10/21/2013  More...
Pain Treatment Biotech Egalet Files for a $69 Million IPO 10/17/2013  More...
Startup Seragon Pharmaceuticals Lands $30 Million in Series A Financing 10/16/2013  More...
Vital Therapies, Inc. (VTI) Files For $86.25 Million IPO 10/14/2013  More...
BIND Therapeutics Scrounges Up $70.5 Million in IPO 9/20/2013  More...
With Support From Celgene (CELG) and Other Investors, Acceleron Pharma Raises $93 Million in IPO 9/19/2013  More...
Five Prime Therapeutics, Inc. (FPRX) Stock Soars After $62 Million IPO 9/18/2013  More...
Civitas Therapeutics Raises $38 Million 9/11/2013  More...
Cubist Pharmaceuticals, Inc. (CBST) Prices $700 Million of Convertible Senior Notes 9/5/2013  More...
Regado Biosciences, Inc. (RGDO) Finally Goes Public, Raised $43 Million 8/22/2013  More...
MicuRx Pharmaceuticals Completes $25 Million Series B Financing 8/22/2013  More...
Orphan Disease Biotech Fate Therapeutics Files for a $69 Million IPO 8/14/2013  More...
Startup Drug-Discovery Company BioMotiv Attracts New Millions and a Key Partner 8/13/2013  More...
GlaxoSmithKline (GSK) Plugs Into Bioelectronics With $50 Million Venture Fund 8/8/2013  More...
Agios Pharmaceuticals Prices Initial Public Offering 7/24/2013  More...
Verastem, Inc. (VSTM) Announces Pricing of Public Offering of Common Stock 7/22/2013  More...
OncoMed Pharmaceuticals, Inc. IPO Rakes in $72 Million 7/18/2013  More...
Intrexon Corporation Files $125 Million IPO 7/10/2013  More...
Cardio3 BioSciences's Recent $29 Million Biotech IPO Relied Heavily on Questionable Research 7/9/2013  More...
PTC Therapeutics, Inc. IPO Raises $125 Million Despite Checkered Past 6/20/2013  More...
bluebird bio Prices Upsized IPO Above the Range at $17 6/19/2013  More...
Iroko Pharmaceuticals Files for a $145 Million IPO 6/19/2013  More...
Onconova Therapeutics Inc. Files for $75 Million IPO 6/18/2013  More...
Epizyme (EPZM) Prices IPO at $15 Per Share, Begins Trading Today 5/31/2013  More...
INSYS Therapeutics Completes $37 Million IPO to Back Medical Marijuana Drug 5/21/2013  More...
Effector Therapeutics Raises $45 Million Series A to Fight Cancer Tumors 5/20/2013  More...
Karyopharm Therapeutics Raises $48.2 Million in Series B Financing 5/20/2013  More...
Esperion Therapeutics, Inc. Files for $70 Million IPO 5/16/2013  More...
Quintiles, Inc. (QTRN)'s $947.4M IPO to Spawn a New Billionaire 5/10/2013  More...
Startup Allecra Therapeutics Raises $19.5 Million Series A Financing 4/18/2013  More...
Portola Pharmaceuticals, Inc. Files for $115 Million IPO 4/15/2013  More...
Biotech Chimerix, Inc. Shines in IPO Debut as Interest Grows in Antiviral Drugs 4/12/2013  More...
Cleave Biosciences Adds $10 Million to Series A Financing 4/9/2013  More...
Biotech Receptos Files for a $86 Million IPO 4/5/2013  More...
Enanta Pharmaceuticals, Inc. Raises $56 Million in IPO 3/21/2013  More...
NABsys, Inc. Raises $20 Million From Investors 3/13/2013  More...
Emergence-Backed Veeva Systems, Inc. Seen Seeking $2 Billion Valuation With IPO 3/12/2013  More...
Omthera Pharmaceuticals, Inc. Files for a $75 Million IPO 3/11/2013  More...
Tesaro, Inc. Nets $91 Million 3/7/2013  More...
Ambit Biosciences Refiles for a $58 Million IPO 2/21/2013  More...
Sophiris Bio Inc. (SHS.TO) Files for a $75 Million IPO 2/19/2013  More...
Third Rock Ventures Launches Jounce Therapeutics With $47 Million 2/15/2013  More...
TetraPhase Pharmaceuticals Files for a $86 Million IPO 2/13/2013  More...
e-Therapeutics plc to Raise $62.7 Million 2/11/2013  More...
IPO Could Value Pfizer Inc. (PFE)'s Zoetis at Up to $12.5 Billion 1/21/2013  More...
InterMune, Inc. (ITMN) Announces Pricing of Concurrent Public Offerings of $105,000,000 Principal Amount of Convertible Senior Notes and 13,500,000 Shares of Common Stock 1/16/2013  More...
Onyx Pharmaceuticals, Inc. (ONXX) Announces Pricing of Public Offering of Common Stock 1/16/2013  More...
Aileron Therapeutics Nabs $12 Million for First-Ever Stapled Peptide Clinical Trial 1/14/2013  More...
Foundation Medicine Expands Series B Financing to $56 Million 1/8/2013  More...
Pfizer Inc. (PFE) to Launch Animal-Health Unit IPO in Early 2013 12/14/2012  More...
Biotech Startup Transcriptic Receives $1.2 Million in Seed Funding Led by Google Ventures 12/14/2012  More...
Sofinnova Ventures Raises $312 Million for Life Sciences 12/11/2012  More...
Fluxion Biosciences Secures $20 Million in Series B Financing 12/4/2012  More...
ArmaGen Technologies, Inc. Announces $17 Million Series A Financing 11/30/2012  More...
Intarcia Therapeutics, Inc. Secures $210 Million Financing to Fund Its Global Phase 3 Program 11/15/2012  More...
Cardioxyl Pharmaceuticals Raises $28 Million in Series B Financing 11/14/2012  More...
Pearl Therapeutics Grabs $65 Million in VC Funding, Moves COPD Drug Toward Phase III Trials 11/13/2012  More...
Visterra, Inc. Boosts Series A to $26 Million, Adds Bill & Melinda Gates Foundation as Investor 11/9/2012  More...
Abbott Laboratories (ABT) Announces Pricing of AbbVie's $14.7 Billion Private Placement Notes Offering 11/5/2012  More...
Puma Biotechnology Raises $138 Million in Public Offering of Common Stock 10/26/2012  More...
Aclaris Therapeutics Raises $21 Million in Series A Financing 10/24/2012  More...
Intercept Pharmaceuticals, Kythera Biopharmaceuticals Take Off in IPOs 10/12/2012  More...
KaloBios Pharmaceuticals, Inc. Files for IPO 10/5/2012  More...
Massachusetts Institute of Technology (MIT) Economist Pitches $30 Billion Cancer Megafund 10/2/2012  More...
Google Inc. Venture Fund Eyes Biotech Start-Ups With $1 Billion in Pocket 9/24/2012  More...
Foundation Medicine, Inc. (FMI) Announces $42.5 Million Series B Financing 9/20/2012  More...
Startup Heart Drug Developer MyoKardia Lands $38 Million 9/20/2012  More...
Selexys Pharmaceuticals Corporation Completes $23 Million Equity Financing and Signs Agreement With Novartis Pharmaceuticals Corporation (NVS) for Up to $665 Million 9/19/2012  More...
Intercept Pharmaceuticals Files for $75 Million IPO 9/5/2012  More...
Regulus Therapeutics, Inc. Files for Up to $58 Million IPO 8/20/2012  More...
KV Pharmaceutical Files for Chapter 11; Cites Makena Drug Woes 8/6/2012  More...
Burrill & Company Touts New Life Sciences Fund Worth $505 Million 8/3/2012  More...
Biotech Start-Up Atterocor Raises $16 Million Series A 8/3/2012  More...
Idenix Pharmaceuticals, Inc. (IDIX) Prices Public Offering of Common Stock 8/2/2012  More...
Durata Therapeutics, Inc. Prices $68 Million IPO 7/19/2012  More...
Agile Therapeutics, Inc. Raises $40 Million in a Series C Financing 7/19/2012  More...
Juventas Therapeutics, Inc. Raises $22.2 Million Series B Financing 7/16/2012  More...
Synageva BioPharma (GEVA) Announces $80 Million Proposed Public Offering of Common Stock 7/10/2012  More...
GenKyoTex S.A. Raises $26 Million for Phase II Development of Diabetic Nephropathy Drug 7/9/2012  More...
Cytokinetics, Inc. (CYTK) Nabs $60 Million Financing 6/20/2012  More...
Tesaro, Inc. Sets Terms for $81 Million US IPO 6/20/2012  More...
Global Blood Therapeutics, Third Rock Ventures’s First West Coast Startup, Gets $41 Million 6/14/2012  More...
Rhythm Drums Up $25 Million to Advance Diabetes and Obesity Drugs 6/13/2012  More...
New Firm Select BioVentures Seeks $200 Million for Biotech Deals in Sunshine State 6/13/2012  More...
Kleiner Perkins Caufield & Byers Launches New $525 Million Venture Fund 5/18/2012  More...
Arena Pharmaceuticals, Inc. (ARNA) Prices Public Offering of Common Stock 5/17/2012  More...
OncoMed Pharmaceuticals, Inc. Files for $115 Million IPO 5/14/2012  More...
Supernus Pharmaceuticals Announces Closing of Initial Public Offering 5/7/2012  More...
Savient Pharmaceuticals, Inc. (SVNT) Plummets as Hedge Fund Claims It's Bankrupt 5/2/2012  More...
Peter Thiel's Breakout Labs Awards Cash to 6 Ambitious Biotech Startups 4/17/2012  More...
Hyperion Therapeutics Files for $58 Million US IPO 4/13/2012  More...
Supernus Pharmaceuticals Sets Terms for $75 Million US IPO 4/12/2012  More...
Merck Teams With Flagship to Bankroll Biotech Start-ups 4/10/2012  More...
BioVentures Closes $268 Million Life Sciences Fund 4/10/2012  More...
Wellcome Trust to Launch $318 Million Biotech Start-up Fund 3/21/2012  More...
GlaxoSmithKline (GSK), Johnson & Johnson (JNJ) Plot $200 Million Biotech Fund With Index Ventures 3/21/2012  More...
Bellicum Pharmaceuticals, Inc. Closes $20 Million Series B Financing 3/8/2012  More...
Rusnano, US Fund to Invest $760 Million in Pharma Venture 3/6/2012  More...
4s3 Bioscience Lands $20 Million in Venture Funding 3/5/2012  More...
Pfizer Inc. (PFE) Mulls $3 Billion Partial IPO for Animal Healthcare Unit: Report 2/21/2012  More...
ChemoCentryx, Inc. (CCXI) Completes IPO 2/14/2012  More...
Ironwood Pharmaceuticals Announces Exercise of Over-Allotment Option in Public Offering of Common Stock 2/13/2012  More...
Celgene (CELG) Pours $15 Million Into Acetylon Pharmaceuticals, Takes "Observer" Role on Board 2/9/2012  More...
Radius Files IPO, Aims for $86 Million 2/7/2012  More...
RaNA Therapeutics, Inc. Emerges With $20.7 Million Startup Financing 1/18/2012  More...
Warp Drive Bio Launches With $125 Million from Third Rock Ventures, Greylock, Sanofi (France) (SAN.PA) 1/10/2012  More...
Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy 1/4/2012  More...
Acceleron Pharma Secures $30 Million Private Financing 12/28/2011  More...
Cell Therapeutics, Inc. (CTIC) Announces Institutional Investors Purchase $20 Million of Preferred Stock and Warrants 12/9/2011  More...
Forbion Capital Raises $50 Million to Invest in Health Companies 12/8/2011  More...
arGEN-X Raises $37 Million in Oversubscribed Series B Round 12/1/2011  More...
Rib-X Pharmaceuticals, Inc. Files for $80 Million IPO 11/28/2011  More...
Fosun Pharma to Float up to $470 Million in Bonds 11/28/2011  More...
Portola Pharmaceuticals, Inc. Announces Completion of $89 Million Financing 11/21/2011  More...
Agios Pharmaceuticals Secures $78 Million Series C Financing 11/17/2011  More...
Clovis Oncology (CLVS) Raises $130 Million in IPO 11/16/2011  More...
NewLink Genetics Raises $43.4 Million in IPO 11/11/2011  More...
Human Genome Sciences, Inc. (HGSI) Prices $430 Million Convertible Notes Offering 11/3/2011  More...
Foundation Medicine Closes Expanded Series A Financing Totaling $33.5 Million; Third Rock Ventures and Google Inc. Ventures Join as Investors 10/18/2011  More...
Topica Pharmaceuticals Announces Completion of $27 Million Series B Financing 10/18/2011  More...
Third Rock Ventures Launches SAGE Therapeutics with $35 Million Backing 10/18/2011  More...
Sofinnova Ventures Raises $440 Million for Biotech-Only VC Fund 10/17/2011  More...
Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies 10/12/2011  More...
Kythera Biopharmaceuticals Raises $37.4 Million Financing 9/19/2011  More...
Merck & Co., Inc. (MRK) Creates a $250 Million Venture Capital Fund 9/16/2011  More...
InterMune, Inc. (ITMN) Announces Pricing of Concurrent Public Offerings of 4,000,000 Shares of Common Stock and $135 Million Principal Amount of Convertible Senior Notes 9/14/2011  More...
Valeritas Announces $150 Million Financing 9/13/2011  More...
Orphazyme Raises $19.6 Million in a Series A Financing Round 9/7/2011  More...
VIVUS, Inc. (VVUS) Adds $45.8 Million 8/24/2011  More...
KalVista Pharmaceuticals Launched With $13 Million Series A Funding to Develop Eye Drugs 8/23/2011  More...
Asymchem Laboratories, Inc. Announces $39 Million in VC Funds 8/22/2011  More...
Yaupon Therapeutics Inc. Secures $14.4 Million in Series D Financing 8/11/2011  More...
Enobia Pharma Raises US $40 Million 8/10/2011  More...
SARcode Pulls in $44 Million Series B Financing 7/18/2011  More...
Verastem, Inc. Nabs $32 Million Series B Financing 7/14/2011  More...
DVS Sciences Raises $14.6 Million in Series A Financing to Advance Commercialization of Novel Single-Cell Analysis Technology 7/14/2011  More...
Merrimack Pharmaceuticals Inc. Files $172.5 Million IPO 7/11/2011  More...
Zafgen Secures $33 Million Series C Financing 7/7/2011  More...
Tesaro, Inc. Snags Huge $101 Million Venture Round to Develop Cancer Drugs 6/21/2011  More...
AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) (AVEO) Gets $100 Million in Stock Offering 6/16/2011  More...
ReVance Therapeutics, Inc. Announces $45 Million Financing 6/10/2011  More...
Rigel Pharmaceuticals, Inc. (RIGL) Pockets $130 Million in Financing, Seeks To Pick up Pfizer Inc. (PFE)'s Ball and Run With it 5/31/2011  More...
Intrexon Corporation Raises $100 Million for Synthetic Biology Initiatives 5/31/2011  More...
Celldex Therapeutics, Inc. (CLDX) Raises $31.5 Million 5/19/2011  More...
Naurex Inc. Raises $18 Million to Advance Novel Antidepressant 5/11/2011  More...
Quintiles, Inc. (QTRN) Seeking $2.23 Billion in Loans for Refinancing 5/11/2011  More...
Takeda Pharmaceuticals Bets on Fate Therapeutics 5/10/2011  More...
Delenex Therapeutics Extends CHF 30.2 Million Series A Financing Round 5/3/2011  More...
Amgen (AMGN) Outlines Strategy, Growth Objectives and Capital Allocation Plans 4/21/2011  More...
Sagene Pharmaceuticals, Inc. Prices IPO at $16 Per Share, Raises $92 Million in Gross Proceeds 4/20/2011  More...
Blueprint Medicines Secures $40 Million Series A Financing to Translate New Molecular Data into Personalized Cancer Treatments 4/11/2011  More...
US-China Based Ascletis, Inc. Raises $100 Million from Private Chinese Investors for Specialty Therapeutics Venture 4/6/2011  More...
Tranzyme Pharma Announces Pricing of Its Initial Public Offering, Raises $53.8M 4/4/2011  More...
Exelixis, Inc. (EXEL) Tacks on $23M 3/17/2011  More...
Solazyme, Inc. Proposes $100 Million IPO and Nasdaq Global Market Listing 3/15/2011  More...
Omthera Pharmaceuticals, Inc. Raises $33.9 Million in Series B Funding Led by New Enterprise Associates 3/14/2011  More...
Nimbus Discovery Unveils First Of Its Kind Drug Discovery Paradigm; Announces Seed Round Co-Led By Bill Gates 3/10/2011  More...
Aerie Pharmaceuticals, Inc. Completes $30 Million Series B Financing to Fund Further Development of Innovative Glaucoma Product Portfolio 3/7/2011  More...
Versartis, Inc. Completes $21 Million Series B Financing 2/16/2011  More...
Celgene (CELG) Announces Additional $1 Billion Share Repurchase Program 2/16/2011  More...
Eli Lilly and Company (LLY) to Raise Nearly $750 Million to Share Drug Development Costs 2/14/2011  More...
AcelRx Pharmaceuticals Prices IPO at $5, Below the Original $12-$14 Range 2/11/2011  More...
Fluidigm Corporation 5.6M-Share IPO Prices At $13.50; Low End Of Prior Estimate 2/10/2011  More...
Pharmasset, Inc. (VRUS) Prices Public Offering of Common Stock 1/21/2011  More...
Dendreon Corporation (DNDN) Announces Pricing of $540 Million Convertible Senior Notes Due 2016 1/14/2011  More...
TetraLogic Pharmaceuticals Closes $23 Million Second Tranche of Series C Financing 1/5/2011  More...
Genocea Biosciences Lands Massive $35M Series B Round 1/3/2011  More...
GlaxoSmithKline (GSK) Offers to Give National Cancer Institute Rebate If Pfizer Inc. (PFE) Cancer Drug Better in Head to Head Clinical Trial 12/29/2010  More...
QuantaLife Raises $17.2M in Series B Financing 12/13/2010  More...
Momenta Pharmaceuticals, Inc. (MNTA) Nabs $57.4M in Stock Offering 12/8/2010  More...
Geron Corporation (GERN) Plans to Raise $87M in Stock Sale 12/7/2010  More...
Genetics Instrument Maker Fluidigm Corporation Refiles for $86 million IPO 12/6/2010  More...
Anacor Pharmaceuticals, Inc. Completes $70 Million Initial Public Offering and Concurrent Private Placement 12/1/2010  More...
Sutro Biopharma Secures $36.5 Million in Series C Financing 11/17/2010  More...





 

//-->